Gene · 6249
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA Expression Profiling, Target Identification, and Validation in Chondrocytes. | Methods Mol Biol | 2021 | 33315201 | PubTator, text mining | PubMed |
| Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma. | J Cell Mol Med | 2021 | 33300278 | PubTator, text mining | PubMed |
| Meiotic Cells Counteract Programmed Retrotransposon Activation via RNA-Binding Translational Repressor Assemblies. | Dev Cell | 2021 | 33278343 | PubTator, text mining | PubMed |
| Host genetics and infectious disease: new tools, insights and translational opportunities. | Nat Rev Genet | 2021 | 33277640 | PubTator, text mining | PubMed |
| A Performance Comparison of Commonly Used Assays to Detect RET Fusions. | Clin Cancer Res | 2021 | 33272981 | PubTator, text mining | PubMed |
| AMPK regulates cell shape of cardiomyocytes by modulating turnover of microtubules through CLIP-170. | EMBO Rep | 2021 | 33251722 | PubTator, text mining | PubMed |
| BUB1 and CENP-U, Primed by CDK1, Are the Main PLK1 Kinetochore Receptors in Mitosis. | Mol Cell | 2021 | 33248027 | PubTator, text mining | PubMed |
| Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels. | RNA | 2021 | 33172965 | PubTator, text mining | PubMed |
| Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. | Mol Cancer Res | 2021 | 33154093 | PubTator, text mining | PubMed |
| Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA-DQ2.5. | Immunology | 2021 | 33064841 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
| HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk. | Hepatology | 2021 | 32931023 | PubTator, text mining | PubMed |
| Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis. | Med | 2021 | 32838362 | PubTator, text mining | PubMed |
| ROS1-dependent cancers - biology, diagnostics and therapeutics. | Nat Rev Clin Oncol | 2021 | 32760015 | PubTator, text mining | PubMed |
| New Twists in Detecting mRNA Modification Dynamics. | Trends Biotechnol | 2021 | 32620324 | PubTator, text mining | PubMed |
| Immunoinformatics: Predicting Peptide-MHC Binding. | Annu Rev Biomed Data Sci | 2020 | 37427310 | PubTator, text mining | PubMed |
| IL-27/IL-27RA signaling may modulate inflammation and progression of benign prostatic hyperplasia via suppressing the LPS/TLR4 pathway. | Transl Cancer Res | 2020 | 35117826 | PubTator, text mining | PubMed |
| A comprehensive assessment of the prognostic role of cell adhesion molecules in acute myeloid leukemia. | Transl Cancer Res | 2020 | 35117360 | PubTator, text mining | PubMed |
| Catalog of 5' fusion partners in RET+ NSCLC Circa 2020. | JTO Clin Res Rep | 2020 | 34589933 | PubTator, text mining | PubMed |
| Large-scale analysis of the position-dependent binding and regulation of human RNA binding proteins. | Quant Biol | 2020 | 34221536 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6249/papers?page=39